Author
Listed:
- Debora L. Gisch
(Indiana University School of Medicine)
- Michelle Brennan
(Saint Louis University)
- Blue B. Lake
(Department of Bioengineering, University of California, San Diego
San Diego Institute of Science, Altos Labs)
- Jeannine Basta
(Washington University in Saint Louis)
- Mark S. Keller
(Harvard Medical School)
- Ricardo Melo Ferreira
(Indiana University School of Medicine)
- Shreeram Akilesh
(University of Washington –)
- Reetika Ghag
(Washington University in Saint Louis)
- Charles Lu
(Washington University in Saint Louis)
- Ying-Hua Cheng
(Indiana University School of Medicine)
- Kimberly S. Collins
(Indiana University School of Medicine)
- Samir V. Parikh
(Ohio State University Wexner Medical Center)
- Brad H. Rovin
(Ohio State University Wexner Medical Center)
- Lynn Robbins
(St. Louis Veteran Affairs Medical Center)
- Lisa Stout
(Washington University in Saint Louis)
- Kimberly Y. Conklin
(Department of Bioengineering, University of California, San Diego)
- Dinh Diep
(Department of Bioengineering, University of California, San Diego)
- Bo Zhang
(Washington University in Saint Louis)
- Amanda Knoten
(Washington University in Saint Louis)
- Daria Barwinska
(Indiana University School of Medicine)
- Mahla Asghari
(Indiana University School of Medicine)
- Angela R. Sabo
(Indiana University School of Medicine)
- Michael J. Ferkowicz
(Indiana University School of Medicine)
- Timothy A. Sutton
(Indiana University School of Medicine)
- Katherine J. Kelly
(Indiana University School of Medicine)
- Ian H. De Boer
(University of Washington –)
- Sylvia E. Rosas
(Joslin Diabetes Center, Harvard Medical School)
- Krzysztof Kiryluk
(Columbia University)
- Jeffrey B. Hodgin
(University of Michigan)
- Fadhl Alakwaa
(University of Michigan)
- Seth Winfree
(University of Nebraska Medical Center)
- Nichole Jefferson
(Kidney Precision Medicine Project Community Engagement Committee)
- Aydın Türkmen
(Istanbul School of Medicine, Division of Nephrology)
- Joseph P. Gaut
(Department of Bioengineering, University of California, San Diego)
- Nils Gehlenborg
(Harvard Medical School)
- Carrie L. Phillips
(Indiana University School of Medicine)
- Tarek M. El-Achkar
(Indiana University School of Medicine)
- Pierre C. Dagher
(Indiana University School of Medicine)
- Takashi Hato
(Indiana University School of Medicine)
- Kun Zhang
(Department of Bioengineering, University of California, San Diego)
- Jonathan Himmelfarb
(University of Washington –)
- Matthias Kretzler
(University of Michigan)
- Shamim Mollah
(Washington University in Saint Louis)
- Sanjay Jain
(Washington University in Saint Louis)
- Michael Rauchman
(Washington University in Saint Louis)
- Michael T. Eadon
(Indiana University School of Medicine)
Abstract
There is a need to define regions of gene activation or repression that control human kidney cells in states of health, injury, and repair to understand the molecular pathogenesis of kidney disease and design therapeutic strategies. Comprehensive integration of gene expression with epigenetic features that define regulatory elements remains a significant challenge. We measure dual single nucleus RNA expression and chromatin accessibility, DNA methylation, and H3K27ac, H3K4me1, H3K4me3, and H3K27me3 histone modifications to decipher the chromatin landscape and gene regulation of the kidney in reference and adaptive injury states. We establish a spatially-anchored epigenomic atlas to define the kidney’s active, silent, and regulatory accessible chromatin regions across the genome. Using this atlas, we note distinct control of adaptive injury in different epithelial cell types. A proximal tubule cell transcription factor network of ELF3, KLF6, and KLF10 regulates the transition between health and injury, while in thick ascending limb cells this transition is regulated by NR2F1. Further, combined perturbation of ELF3, KLF6, and KLF10 distinguishes two adaptive proximal tubular cell subtypes, one of which manifested a repair trajectory after knockout. This atlas will serve as a foundation to facilitate targeted cell-specific therapeutics by reprogramming gene regulatory networks.
Suggested Citation
Debora L. Gisch & Michelle Brennan & Blue B. Lake & Jeannine Basta & Mark S. Keller & Ricardo Melo Ferreira & Shreeram Akilesh & Reetika Ghag & Charles Lu & Ying-Hua Cheng & Kimberly S. Collins & Sami, 2024.
"The chromatin landscape of healthy and injured cell types in the human kidney,"
Nature Communications, Nature, vol. 15(1), pages 1-21, December.
Handle:
RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-023-44467-6
DOI: 10.1038/s41467-023-44467-6
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-023-44467-6. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.